Clinical PET of neuroendocrine tumors using 64Cu-DOTATATE: first-in-humans study
Clinical PET of neuroendocrine tumors using 64Cu-DOTATATE: first-in-humans study
About this item
Full title
Author / Creator
Publisher
United States
Journal title
Language
English
Formats
Publication information
Publisher
United States
Subjects
More information
Scope and Contents
Contents
The use of positron emitter-labeled compounds for somatostatin receptor imaging (SRI) has become attractive because of the prospect of improved spatial resolution, accelerated imaging procedures, and the ability to quantify tissue radioactivity concentrations. This paper provides results from first-in-humans use of (64)Cu-DOTATATE, an avidly bindin...
Alternative Titles
Full title
Clinical PET of neuroendocrine tumors using 64Cu-DOTATATE: first-in-humans study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1551630162
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1551630162
Other Identifiers
ISSN
0161-5505
E-ISSN
1535-5667
DOI
10.2967/jnumed.111.101469
